United Health Products, Inc. (UEEC)
USD 0.23
(-5.7%)
USD 0.23
(-5.7%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 284.64 Thousand USD | -18.8% |
| 2022 | 350.52 Thousand USD | 1207.99% |
| 2021 | 26.79 Thousand USD | -87.66% |
| 2020 | 217.1 Thousand USD | 132.26% |
| 2019 | 93.47 Thousand USD | -25.8% |
| 2018 | 125.97 Thousand USD | -84.52% |
| 2017 | 813.56 Thousand USD | 313.05% |
| 2016 | 196.96 Thousand USD | 275.39% |
| 2015 | 52.46 Thousand USD | 27.93% |
| 2014 | 41.01 Thousand USD | -52.03% |
| 2013 | 85.5 Thousand USD | -43.01% |
| 2012 | 150.03 Thousand USD | -40.04% |
| 2011 | 250.22 Thousand USD | -35.9% |
| 2010 | 390.39 Thousand USD | -39.15% |
| 2009 | 641.56 Thousand USD | 144.76% |
| 2008 | 262.12 Thousand USD | 1102.23% |
| 2007 | 21.8 Thousand USD | -31.74% |
| 2006 | 31.94 Thousand USD | 0.0% |
| 2005 | - USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 121.68 Thousand USD | -47.85% |
| 2024 Q1 | 233.32 Thousand USD | -18.03% |
| 2023 Q3 | 335.66 Thousand USD | -22.64% |
| 2023 FY | 284.64 Thousand USD | -18.8% |
| 2023 Q2 | 433.89 Thousand USD | 42.77% |
| 2023 Q1 | 303.9 Thousand USD | -13.3% |
| 2023 Q4 | 284.64 Thousand USD | -15.2% |
| 2022 Q4 | 350.52 Thousand USD | -22.43% |
| 2022 Q2 | 59.09 Thousand USD | -23.69% |
| 2022 Q1 | 77.44 Thousand USD | 188.98% |
| 2022 FY | 350.52 Thousand USD | 1207.99% |
| 2022 Q3 | 451.91 Thousand USD | 664.69% |
| 2021 Q4 | 26.79 Thousand USD | -91.87% |
| 2021 FY | 26.79 Thousand USD | -87.66% |
| 2021 Q1 | 396.58 Thousand USD | 82.67% |
| 2021 Q3 | 329.44 Thousand USD | 70.23% |
| 2021 Q2 | 193.53 Thousand USD | -51.2% |
| 2020 Q1 | 132.52 Thousand USD | 41.78% |
| 2020 Q3 | 185.44 Thousand USD | -1.82% |
| 2020 Q4 | 217.1 Thousand USD | 17.07% |
| 2020 FY | 217.1 Thousand USD | 132.26% |
| 2020 Q2 | 188.88 Thousand USD | 42.52% |
| 2019 Q4 | 93.47 Thousand USD | -60.03% |
| 2019 Q3 | 233.86 Thousand USD | -63.27% |
| 2019 FY | 93.47 Thousand USD | -25.8% |
| 2019 Q2 | 636.72 Thousand USD | 530.33% |
| 2019 Q1 | 101.01 Thousand USD | -19.82% |
| 2018 Q1 | 781.12 Thousand USD | -3.99% |
| 2018 Q4 | 125.97 Thousand USD | -80.56% |
| 2018 Q2 | 940.18 Thousand USD | 20.36% |
| 2018 Q3 | 648.12 Thousand USD | -31.06% |
| 2018 FY | 125.97 Thousand USD | -84.52% |
| 2017 Q4 | 813.56 Thousand USD | 166.05% |
| 2017 Q2 | 260.3 Thousand USD | -16.43% |
| 2017 FY | 813.56 Thousand USD | 313.05% |
| 2017 Q1 | 311.46 Thousand USD | 58.14% |
| 2017 Q3 | 305.79 Thousand USD | 17.48% |
| 2016 FY | 196.96 Thousand USD | 275.39% |
| 2016 Q3 | 284.85 Thousand USD | -15.63% |
| 2016 Q4 | 196.96 Thousand USD | -30.85% |
| 2016 Q1 | 75.91 Thousand USD | 44.69% |
| 2016 Q2 | 337.6 Thousand USD | 344.7% |
| 2015 Q3 | 667.97 Thousand USD | 50.28% |
| 2015 Q1 | 509.87 Thousand USD | 1143.13% |
| 2015 Q2 | 444.5 Thousand USD | -12.82% |
| 2015 Q4 | 52.46 Thousand USD | -92.15% |
| 2015 FY | 52.46 Thousand USD | 27.93% |
| 2014 Q2 | 21.36 Thousand USD | -68.9% |
| 2014 Q4 | 41.01 Thousand USD | 98.99% |
| 2014 FY | 41.01 Thousand USD | -52.03% |
| 2014 Q1 | 68.68 Thousand USD | -19.67% |
| 2014 Q3 | 20.61 Thousand USD | -3.51% |
| 2013 Q4 | 85.5 Thousand USD | -28.32% |
| 2013 Q2 | 101.48 Thousand USD | -18.81% |
| 2013 Q3 | 119.29 Thousand USD | 17.55% |
| 2013 Q1 | 125 Thousand USD | -16.68% |
| 2013 FY | 85.5 Thousand USD | -43.01% |
| 2012 Q3 | 175.08 Thousand USD | -12.5% |
| 2012 FY | 150.03 Thousand USD | -40.04% |
| 2012 Q4 | 150.03 Thousand USD | -14.31% |
| 2012 Q2 | 200.09 Thousand USD | -11.13% |
| 2012 Q1 | 225.14 Thousand USD | -10.02% |
| 2011 FY | 250.22 Thousand USD | -35.9% |
| 2011 Q1 | 407.49 Thousand USD | 4.38% |
| 2011 Q3 | 358.36 Thousand USD | -1.75% |
| 2011 Q2 | 364.75 Thousand USD | -10.49% |
| 2011 Q4 | 250.22 Thousand USD | -30.18% |
| 2010 Q2 | 743.95 Thousand USD | 18.46% |
| 2010 Q3 | 623.68 Thousand USD | -16.17% |
| 2010 Q4 | 390.39 Thousand USD | -37.4% |
| 2010 FY | 390.39 Thousand USD | -39.15% |
| 2010 Q1 | 627.99 Thousand USD | -2.12% |
| 2009 FY | 641.56 Thousand USD | 144.76% |
| 2009 Q1 | 289.96 Thousand USD | 10.62% |
| 2009 Q2 | 719.63 Thousand USD | 148.18% |
| 2009 Q3 | 702.07 Thousand USD | -2.44% |
| 2009 Q4 | 641.56 Thousand USD | -8.62% |
| 2008 Q4 | 262.12 Thousand USD | -3.03% |
| 2008 Q3 | 270.3 Thousand USD | 1104.15% |
| 2008 Q2 | 22.44 Thousand USD | -26.43% |
| 2008 Q1 | 30.51 Thousand USD | 39.95% |
| 2008 FY | 262.12 Thousand USD | 1102.23% |
| 2007 Q1 | 61.07 Thousand USD | 91.21% |
| 2007 FY | 21.8 Thousand USD | -31.74% |
| 2007 Q4 | 21.8 Thousand USD | 12.46% |
| 2007 Q3 | 19.38 Thousand USD | -44.88% |
| 2007 Q2 | 35.17 Thousand USD | -42.41% |
| 2006 Q4 | 31.94 Thousand USD | -38.54% |
| 2006 Q3 | 51.96 Thousand USD | 0.0% |
| 2006 FY | 31.94 Thousand USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | 84.514% |
| Ansell Limited | 3.23 Billion USD | 99.991% |
| Ansell Limited | 3.24 Billion USD | 99.991% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | 99.942% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | 5.233% |
| Psykey, Inc. | 1.72 Million USD | 83.522% |
| ConvaTec Group Plc | 3.7 Billion USD | 99.992% |
| ConvaTec Group Plc | 3.71 Billion USD | 99.992% |
| Encision Inc. | 3.81 Million USD | 92.53% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | 56.335% |
| LifePoint, Inc. | 8.8 Million USD | 96.769% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 98.216% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | 68.196% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | 94.814% |
| Reflect Scientific, Inc. | 2.66 Million USD | 89.335% |
| SmileDirectClub, Inc. | 597.06 Million USD | 99.952% |
| Sector 10, Inc. | 1000.00 USD | -28364.3% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 99.994% |
| SheerVision, Inc. | 837.56 Thousand USD | 66.015% |
| Vasamed, Inc. | 1.6 Million USD | 82.213% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -27.544% |
| Yubo International Biotech Limited | 2.34 Million USD | 87.88% |